Croda International Plc (LON:CRDA – Get Free Report) insider Ian Bull acquired 500 shares of the business’s stock in a transaction that occurred on Friday, August 1st. The shares were acquired at an average cost of GBX 2,643 ($35.13) per share, for a total transaction of £13,215 ($17,563.80).
Ian Bull also recently made the following trade(s):
- On Tuesday, May 6th, Ian Bull bought 1,000 shares of Croda International stock. The stock was purchased at an average price of GBX 3,011 ($40.02) per share, with a total value of £30,110 ($40,018.61).
Croda International Trading Down 1.4%
LON CRDA opened at GBX 2,590 ($34.42) on Tuesday. The company has a market capitalization of £3.62 billion, a PE ratio of 22.26, a P/E/G ratio of 1.40 and a beta of 0.74. The company has a fifty day moving average of GBX 2,958.70 and a 200 day moving average of GBX 3,018.67. Croda International Plc has a 1 year low of GBX 2,527 ($33.59) and a 1 year high of GBX 4,335 ($57.62). The company has a debt-to-equity ratio of 30.90, a current ratio of 2.72 and a quick ratio of 2.25.
Analysts Set New Price Targets
Several equities research analysts have recently commented on the stock. Berenberg Bank lowered their price objective on shares of Croda International from GBX 3,800 ($50.51) to GBX 3,100 ($41.20) and set a “buy” rating for the company in a research note on Tuesday, July 29th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Croda International from GBX 3,400 ($45.19) to GBX 3,000 ($39.87) and set a “hold” rating for the company in a research report on Tuesday, July 29th. Citigroup decreased their target price on shares of Croda International from GBX 3,550 ($47.18) to GBX 3,300 ($43.86) and set a “neutral” rating for the company in a research report on Tuesday, April 29th. Finally, JPMorgan Chase & Co. upgraded shares of Croda International to an “overweight” rating in a research report on Wednesday, July 30th.
Get Our Latest Report on Croda International
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
Read More
- Five stocks we like better than Croda International
- How to Invest in Small Cap Stocks
- Analysts Make a Quantum Bet on D-Wave’s Cryogenic Packaging
- Following Congress Stock Trades
- Traders Turn Bullish on Housing Stocks Again—3 Leading the Way
- What is a Microcap Stock? Everything You Need to Know
- Onsemi’s August Pullback Is a Signal to Buy for Tech Investors
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.